Comparing the Garmin Venu 3 / Garmin Venu 4 for Non-Invasive Vital Sign Monitoring to a Hospital-Grade Monitor
Ziekenhuis Oost-Limburg
30 participants
Oct 12, 2025
INTERVENTIONAL
Conditions
Summary
This clinical trial evaluates the accuracy of the Garmin Venu 3 / Garmin Venu 4 smartwatch in measuring vital signs (heart rate, respiratory rate, SpO₂) compared to the clinically validated Philips IntelliVue X2. The study aims to determine whether the consumer-grade smartwatch can provide reliable data for remote patient monitoring, early hospital discharge, and chronic disease management, offering a more accessible and affordable alternative to MDR-certified devices.
Eligibility
Inclusion Criteria4
- Provide signed and dated informed consent
- Adults older than 18 years of age
- Speak and understand the Dutch language
- Hospitalized for at least another 24 hours
Exclusion Criteria2
- Life expectancy is less than 30 days
- Patient is isolated due to infection control
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Each participant will be continuously monitored for a minimum of one full night and up to a maximum of 24 hours using both a hospital-grade monitor (Philips IntelliVue X2) and a Garmin Venu 3 or Garmin Venu 4 smartwatch.
Upon completion of the monitoring period, participants will be asked to complete the Smartwatch Rating Scale (SRS) questionnaire
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07360678